2009-11-10 03:07:01 -
Biogen Idec Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/biogen-idec- ..
Biogen Idec Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Biogen Idec Inc. (Biogen) is a biotechnology company, involved in the development, manufacturing and commercialization of novel therapies used in the areas of oncology, neurology, immunology and cardiology. The company operates in more than 90 countries worldwide and principally operates in Canada, Australia, Japan and Europe. Biogen has 47 subsidiaries. The company is headquartered in Massachusetts, the U.S. Recently in April 2009, the company received approval from U.S. Food and Drug Administration (FDA) for its high titer process for the production of multiple sclerosis drug TYSABRI (natalizumab).
The Biogen Idec Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information.
The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
